Franco M Buonaguro
Overview
Explore the profile of Franco M Buonaguro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavalluzzo B, Viuff M, Tvingsholm S, Ragone C, Manolio C, Mauriello A, et al.
J Exp Clin Cancer Res
. 2024 Mar;
43(1):87.
PMID: 38509571
Background: We have recently shown extensive sequence and conformational homology between tumor-associated antigens (TAAs) and antigens derived from microorganisms (MoAs). The present study aimed to assess the breadth of T-cell...
2.
Isaguliants M, Ivanov A, Buonaguro F
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398209
Infections are responsible for approximately one out of six cases of cancer worldwide [...].
3.
Caponigro V, Tornesello A, Merciai F, La Gioia D, Salviati E, Basilicata M, et al.
J Transl Med
. 2023 Dec;
21(1):918.
PMID: 38110968
Background: Early diagnosis of hepatocellular carcinoma (HCC) is essential towards the improvement of prognosis and patient survival. Circulating markers such as α-fetoprotein (AFP) and micro-RNAs represent useful tools but still...
4.
Tornesello M, Cerasuolo A, Starita N, Amiranda S, Bonelli P, Tuccillo F, et al.
Front Cell Dev Biol
. 2023 Nov;
11:1286683.
PMID: 38033865
Telomerase activity and telomere elongation are essential conditions for the unlimited proliferation of neoplastic cells. Point mutations in the core promoter region of the telomerase reverse transcriptase (TERT) gene have...
5.
Sokolovska L, Isaguliants M, Buonaguro F
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37514990
The COVID-19 pandemic put focus on various aspects of vaccine research and development. These include mass vaccination strategies, vaccination compliance and hesitancy, acceptance of novel vaccine approaches, preclinical and animal...
6.
Buonaguro L, Cavalluzzo B, Mauriello A, Ragone C, Tornesello A, Buonaguro F, et al.
Mol Aspects Med
. 2023 Jun;
92:101192.
PMID: 37295175
Cancer prevention is one of the aim with the highest priority in order to reduce the burden of cancer diagnosis and treatment on individuals as well as on healthcare systems....
7.
Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro F, Tornesello M, et al.
Mol Cancer
. 2023 Apr;
22(1):75.
PMID: 37101139
Background: The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift...
8.
Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients
Tornesello A, Botti C, Micillo A, Labonia F, Arpino S, Isgro M, et al.
J Transl Med
. 2023 Feb;
21(1):123.
PMID: 36788606
Background: The infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has unpredictable manifestations of coronavirus disease (COVID-19) and variable clinical course with some patients being asymptomatic whereas others experiencing...
9.
Tornesello M, Cerasuolo A, Starita N, Tornesello A, Bonelli P, Tuccillo F, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358677
Human oncoviruses are able to subvert telomerase function in cancer cells through multiple strategies. The activity of the catalytic subunit of telomerase (TERT) is universally enhanced in virus-related cancers. Viral...
10.
Manolio C, Ragone C, Cavalluzzo B, Mauriello A, Tornesello M, Buonaguro F, et al.
J Transl Med
. 2022 Oct;
20(1):472.
PMID: 36243758
Background: People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry...